<VariationArchive RecordType="classified" VariationID="5663" VariationName="NM_014946.4(SPAST):c.453dup (p.Gly152fs)" VariationType="Duplication" Accession="VCV000005663" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-10-11" MostRecentSubmission="2019-10-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20702" VariationID="5663">
      <GeneList>
        <Gene Symbol="SPAST" FullName="spastin" GeneID="6683" HGNC_ID="HGNC:11233" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="32063556" stop="32157637" display_start="32063556" display_stop="32157637" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="32288679" stop="32382705" display_start="32288679" display_stop="32382705" Strand="+" />
          </Location>
          <OMIM>604277</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SPAST">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SPAST">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_014946.4(SPAST):c.453dup (p.Gly152fs)</Name>
      <CanonicalSPDI>NC_000002.12:32087526:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="32087526" stop="32087527" display_start="32087526" display_stop="32087527" variantLength="1" positionVCF="32087526" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="32312595" stop="32312596" display_start="32312595" display_stop="32312596" variantLength="1" positionVCF="32312595" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>G151fs</ProteinChange>
      <ProteinChange>G152fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363823.2" sequenceAccession="NM_001363823" sequenceVersion="2" change="c.450dup">
            <Expression>NM_001363823.2:c.450dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350752.1" sequenceAccession="NP_001350752" sequenceVersion="1" change="p.Gly151fs">
            <Expression>NP_001350752.1:p.Gly151fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363875.2" sequenceAccession="NM_001363875" sequenceVersion="2" change="c.450dup">
            <Expression>NM_001363875.2:c.450dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350804.1" sequenceAccession="NP_001350804" sequenceVersion="1" change="p.Gly151fs">
            <Expression>NP_001350804.1:p.Gly151fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377959.1" sequenceAccession="NM_001377959" sequenceVersion="1" change="c.453dup">
            <Expression>NM_001377959.1:c.453dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364888.1" sequenceAccession="NP_001364888" sequenceVersion="1" change="p.Gly152fs">
            <Expression>NP_001364888.1:p.Gly152fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014946.4" sequenceAccession="NM_014946" sequenceVersion="4" change="c.453dup" MANESelect="true">
            <Expression>NM_014946.4:c.453dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055761.2" sequenceAccession="NP_055761" sequenceVersion="2" change="p.Gly152fs">
            <Expression>NP_055761.2:p.Gly152fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199436.2" sequenceAccession="NM_199436" sequenceVersion="2" change="c.453dup">
            <Expression>NM_199436.2:c.453dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_955468.1" sequenceAccession="NP_955468" sequenceVersion="1" change="p.Gly152fs">
            <Expression>NP_955468.1:p.Gly152fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.32312598dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.32312598dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.32087529dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.32087529dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008730.1" sequenceAccession="NG_008730" sequenceVersion="1" change="g.28919dup">
            <Expression>NG_008730.1:g.28919dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_714" sequenceAccession="LRG_714">
            <Expression>LRG_714:g.28919dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_714t1" sequenceAccession="LRG_714t1">
            <Expression>LRG_714t1:c.453dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_714p1" sequenceAccession="LRG_714p1" change="p.Gly152fs">
            <Expression>LRG_714p1:p.Gly152fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA253554" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604277.0008" DB="OMIM" />
        <XRef Type="rs" ID="587777753" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014946.4(SPAST):c.453dup (p.Gly152fs) AND Hereditary spastic paraplegia 4" Accession="RCV000006017" Version="3">
        <ClassifiedConditionList TraitSetID="6399">
          <ClassifiedCondition DB="MedGen" ID="C1866855">Hereditary spastic paraplegia 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-10-11" MostRecentSubmission="2019-10-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10699187</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6399" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4415" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraplegia autosomal dominant 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 4</ElementValue>
                <XRef ID="MONDO:0008438" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 4, autosomal dominant</ElementValue>
                <XRef ID="Spastic+paraplegia+4/6695" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPG4</ElementValue>
                <XRef Type="MIM" ID="182601" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSP2</ElementValue>
                <XRef Type="MIM" ID="182601" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 4 (SPG4; also known as SPAST-HSP) is characterized by insidiously progressive bilateral lower-limb gait spasticity. More than 50% of affected individuals have some weakness in the legs and impaired vibration sense at the ankles. Sphincter disturbances are very common. Onset is insidious, mostly in young adulthood, although symptoms may start as early as age one year and as late as age 76 years. Intrafamilial variation is considerable.</Attribute>
                <XRef ID="NBK1160" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4925" />
                <XRef ID="4925" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301339</ID>
                <ID Source="BookShelf">NBK1160</ID>
              </Citation>
              <XRef ID="100985" DB="Orphanet" />
              <XRef ID="C1866855" DB="MedGen" />
              <XRef ID="MONDO:0008438" DB="MONDO" />
              <XRef Type="MIM" ID="182601" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26199" SubmissionDate="2019-10-08" DateLastUpdated="2019-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604277.0008_SPASTIC PARAPLEGIA 4" title="SPAST, 1-BP INS, 578A_SPASTIC PARAPLEGIA 4" />
        <ClinVarAccession Accession="SCV000026199" DateUpdated="2019-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a member of a family with spastic paraplegia-4 (SPG4; 182601), Fonknechten et al. (2000) identified a heterozygous single base insertion of A after nucleotide 578 in exon 2 of the SPAST gene, resulting in a premature termination codon 2 amino acids downstream from the insertion.</Attribute>
              <Citation>
                <ID Source="PubMed">10699187</ID>
              </Citation>
              <XRef DB="OMIM" ID="182601" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPAST" />
          </GeneList>
          <Name>SPAST, 1-BP INS, 578A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 578A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604277.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARAPLEGIA 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26199" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC PARAPLEGIA 4" MappingRef="Preferred">
        <MedGen CUI="C1866855" Name="Hereditary spastic paraplegia 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

